Author | Robert A. Huddart, MB, PhD, BS

Articles

Hypofractionated Regimen Safe, Feasible in Elderly Bladder Cancer Patients

November 08, 2017

In this interview we discuss results of the HYBRID trial, which tested a hypofractionated regimen of 36 Gy over six fractions in elderly muscle-invasive bladder cancer patients who were ineligible for standard treatments.